SIGN UP
LOG IN
R
RANI
Rani Therapeutics Holdings, Inc.
0.54
0.00+0.68%After Hours: 0.5400 +0.0046 +0.86%16:55 07/03 EDT
OPEN/PREV CLOSE0.5300/0.5318
TODAY RANGE0.5242-0.5550
VOL112.61K
MARKET CAP30.81M
52 WEEK RANGE0.4619-4.190
AVG VOL (3M)457.54K
% TURNOVER0.20%
TURNOVER--
P/E (TTM)-0.5438
% RANGE4.85%
EPS(TTM)-0.9846
P/E(FORWARD)-0.8777
P/B-10.0829
BVPS-0.0531
DIVIDEND--
P/S29.91
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.98M
SHARES OUTSTANDING57.54M
NEXT EARNINGS--
FREE FLOAT24.24M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·06/26 20:33
Rani Therapeutics Faces Nasdaq Non-Compliance Notice
Benzinga·06/26 20:09
Rani Therapeutics Holdings Announces Nasdaq Noncompliance Notice
Benzinga·06/05 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·05/29 20:34
Rani Therapeutics Approves Key Proposals at Annual Meeting
Benzinga·05/22 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·05/20 13:17
Rani Therapeutics Secures $4.3M via Series D Warrant
Reuters·05/19 12:00
RANI THERAPEUTICS ANNOUNCES RESEARCH AGREEMENT WITH CHUGAI
Dow Jones·05/16 17:43
Rani Therapeutics Price Target Cut to $4.00/Share From $14.00 by Oppenheimer
Dow Jones·05/16 17:43
Rani Therapeutics Is Maintained at Outperform by Oppenheimer
Benzinga·05/16 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.